Nutra Pharma Financials

Nutra Pharma Stock Summary

Nutra Pharma competes with Rezolute, Tempest Therapeutics, Forte Biosciences, Dyadic International, and DiaMedica Therapeutics. Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company was incorporated in 2000 and is based in Plantation, Florida. NUTRA PHARMA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.

Nutra Pharma Key Financial Ratios

Nutra Pharma's financial ratios allow both analysts and investors to convert raw data from Nutra Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of Nutra Pharma over time and compare it to other companies across industries.

Nutra Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nutra Pharma's current stock value. Our valuation model uses many indicators to compare Nutra Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nutra Pharma competition to find correlations between indicators driving Nutra Pharma's intrinsic value. More Info.Nutra Pharma Corp is rated below average in return on asset category among its peers. It is considered to be number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nutra Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nutra Pharma's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Nutra Pharma Market Pulse

Along with financial statement analysis, the daily predictive indicators of Nutra Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nutra Pharma Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nutra Pharma Corp based on widely used predictive technical indicators. In general, we focus on analyzing Nutra Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nutra Pharma's daily price indicators and compare them against related drivers.

When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.